Great Lakes Advisors LLC Makes New Investment in Amrize Ltd $AMRZ

Great Lakes Advisors LLC bought a new position in shares of Amrize Ltd (NYSE:AMRZFree Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 318,488 shares of the company’s stock, valued at approximately $16,975,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. MCF Advisors LLC bought a new position in shares of Amrize in the fourth quarter valued at about $27,000. Basepoint Wealth LLC bought a new stake in Amrize during the 4th quarter worth about $33,000. Laurel Wealth Advisors LLC bought a new stake in Amrize during the 4th quarter worth about $34,000. Itau Unibanco Holding S.A. increased its position in Amrize by 150.0% in the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after acquiring an additional 450 shares in the last quarter. Finally, US Bancorp DE bought a new position in shares of Amrize in the third quarter worth about $38,000.

Insider Transactions at Amrize

In related news, insider Stephen S. Clark bought 5,260 shares of the business’s stock in a transaction on Tuesday, August 11th. The shares were purchased at an average price of $47.31 per share, with a total value of $248,850.60. Following the completion of the purchase, the insider owned 10,637 shares of the company’s stock, valued at $503,236.47. This represents a 97.82% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Nollaig Forrest bought 2,000 shares of the firm’s stock in a transaction dated Friday, May 22nd. The shares were bought at an average price of $50.25 per share, with a total value of $100,500.00. Following the completion of the transaction, the insider directly owned 20,139 shares in the company, valued at approximately $1,011,984.75. This trade represents a 11.03% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last ninety days, insiders have acquired 18,328 shares of company stock valued at $872,739. Corporate insiders own 0.54% of the company’s stock.

Amrize Trading Down 2.5%

AMRZ opened at $44.59 on Wednesday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73. The company has a market cap of $24.66 billion, a price-to-earnings ratio of 20.55, a price-to-earnings-growth ratio of 1.00 and a beta of 0.12. The firm has a 50 day simple moving average of $50.95 and a 200 day simple moving average of $54.34. Amrize Ltd has a fifty-two week low of $44.30 and a fifty-two week high of $65.94.

Amrize (NYSE:AMRZGet Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The business had revenue of $3.50 billion during the quarter. On average, sell-side analysts anticipate that Amrize Ltd will post 2.72 earnings per share for the current year.

Amrize Announces Dividend

The business also recently disclosed a dividend, which will be paid on Wednesday, August 26th. Investors of record on Tuesday, August 18th will be issued a $0.11 dividend. The ex-dividend date is Tuesday, August 18th. Amrize’s dividend payout ratio is currently 20.28%.

Wall Street Analysts Forecast Growth

AMRZ has been the topic of a number of research reports. Truist Financial reiterated a “hold” rating and set a $48.00 target price (down from $65.00) on shares of Amrize in a research report on Tuesday, July 7th. Sanford C. Bernstein restated an “outperform” rating on shares of Amrize in a research report on Monday, June 22nd. Vertical Research raised Amrize from a “hold” rating to a “buy” rating and set a $70.00 price objective on the stock in a report on Friday, May 1st. Wells Fargo & Company decreased their price objective on Amrize from $65.00 to $58.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 8th. Finally, Weiss Ratings raised Amrize from a “sell (d+)” rating to a “hold (c)” rating in a research note on Thursday, August 13th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $60.57.

View Our Latest Report on AMRZ

Amrize Company Profile

(Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Read More

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZFree Report).

Institutional Ownership by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.